Webinars
Webinar: ADC’s are back stronger than ever: how, why & what’s next
Summary: Mike Riley, President, Catalent Biologics, will discuss the latest trends in ADC discovery and development, with a focus on how next generation pipelines are being shaped by payload and linker chemistry innovations, including those from Catalent’s award-winning SMARTag® ADC platform.
View Now
Executive Summary
The Keys to Success when Switching from Vials to Prefilled Syringes and Intravenous to Subcutaneous Formulations for Biologics
This article describes the benefits of transitioning from IV to SQ administration, considers the advantages of using PFSs, and explores challenges and solutions for transitioning from vials to PFS.
View Now
Webinars
Leveraging Post-Translational Modifications & Bio-Functional Assays for Characterization of Charged Variants
During this webinar, Catalent experts will discuss challenges associated with charged variants of biotherapeutic products, including monoclonal antibodies and fusion proteins.
View Now
Webinars
Choose Your Partner Wisely-Lessons Learned to Accelerate Product Development
Listen in as Mike and Darren share how new modalities and manufacturing technologies have altered the partnership landscape between developers and CDMOs.
View Now
Webinars
Strategic Considerations for Scaling Up the Manufacturing of Cell Therapies
Join us as our panel of experts discuss key manufacturing challenges for early and late-stage gene-enabled cell therapy programs, as well as how to overcome them through effective partnerships.
View Now
Webinars
Overcoming Manufacturing Challenges for Gene-Enabled Cell Therapies
Summary: Join us as our panel of experts discuss key manufacturing challenges for early and late-stage gene-enabled cell therapy programs, as well as how to overcome them through effective partnerships.
View Now
Video
Choosing a CDMO Partner for Your Late-Stage and Commercial Biologics Programs
Summary: Learn more on considerations for choosing the right CDMO for your late-stage biotherapeutics programs in this interview with Stacey Treichler, Ph.D., Director, Head of Marketing & Strategy, BioModalities, Catalent Biologics.
View Now
Video
The Unique Challenges of Lipid Nanoparticle Development and Manufacturing
Summary: Breaking New Ground: Turning mRNA into an Established Therapeutic Modality (Video 3 of 3 in the mRNA fireside chat series with Catalent’s experts).
View Now
Video
mRNA Development and Manufacturing - CMC challenges and Solutions
Summary: Breaking New Ground: Turning mRNA into an Established Therapeutic Modality (Video 2 of 3 in the mRNA fireside chat series with Catalent’s experts).
View Now
Video
mRNA: A New Option for Vaccines and Therapeutics
Summary: Breaking New Ground: Turning mRNA into an Established Therapeutic Modality (Video 1 of 3 in the mRNA fireside chat series with Catalent’s experts).
View Now
